Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development

Drug Discovery & Development

MEI Pharma begins dosing in ME-344 Phase Ib trial for small cell lung and ovarian cancers By PBR Staff Writer
US-based MEI Pharma has dosed the first patient in a cohort-expansion stage of its Phase Ib clinical trial of ME-344 in combination with topotecan to treat patients with small cell lung or ovarian cancer who failed initial therapy.
Drug Research > Drug Discovery & Development > News
Relmada adds $15m in capital to accelerate development of pain treatment drugs Relmada Therapeutics, a biopharmaceutical firm with four novel pain treatment drugs currently under development in its pipeline, has received a healthy injection of more than $15m in capital last week that will assist the company in the advancement of its work to bring those products to the largest drug prescription market in the world - the treatment of pain.
Drug Research > Drug Discovery & Development > News Aileron Therapeutics secures $33m in series E financing to advance cancer drug development Aileron Therapeutics, a clinical stage biopharmaceutical company that is developing first-in-class therapeutics based on its proprietary Stapled Peptide drug platform, has announced that it has secured $33m in an extension to its Series E equity financing, bringing the total raised in this round to $48m.
Drug Research > Drug Discovery & Development > News
See more Drug Discovery & Development news

Latest Drug Discovery & Development News and Insight

View all Drug Discovery & Development news or find news targeted to your interests
Serialisation
Millions of people die every year due to erroneous treatment with counterfeit drugs. To break the cycle with counterfeit drugs, authorities in most major markets are putting regulations into place to enhance patient’s safety. NNIT and NNE Pharmaplan offer a full end-to-end Track and Trace programme covering all aspects of serialisation, from packaging to the point of dispense. Learn more about NNIT and find out how you comply with the serialisation requirements.
Drug Research > Drug Discovery & Development > Products
Quality Management
Effective quality management processes in the life science industry are critical to meet the intense regulatory requirements.NNIT can ensure you have the highest level of inspection readiness with full document compliance and validation, according to FDA and EMA requirements.
Drug Research > Drug Discovery & Development > Products
Regulatory Affairs
The burden of regulation imposed by national health system legislation and regulatory authorities is continually growing. NNIT can help you use IT to comply with new and upcoming regulations from drug development and regulatory submissions to post-marketing while ensuring that you can manage your data and improve collaboration across your organisation.
Drug Research > Drug Discovery & Development > Products
Drug Development
Transforming a compound into a drug is a massive investment. An integrated IT strategy across your clinical value chain can maximise this investment and speed up time to market.
Drug Research > Drug Discovery & Development > Products
Case Stories
NNIT started life as the IT department of an international pharmaceutical company. This has given us an insiders’ understanding of the way the life sciences industry works. Our people are united by a high level of IT expertise coupled with a commitment to deliver the highest level of quality. In short, we go out of our way to make sure your IT processes increase your business efficiency and support your organisational ambitions.
Drug Research > Drug Discovery & Development > Case Studies
Sign up to NNIT’s Newsletter
| By NNIT
Sign up to NNIT’s newsletter and receive inspiration on how IT can create value for life sciences companies. You'll get articles, whitepapers, cases and invitations to webinars. Sign up here: http://www.nnit.com/pages/news.aspx#/
Drug Research > Drug Discovery & Development > White Papers
Aileron Therapeutics secures $33m in series E financing to advance cancer drug development
Aileron Therapeutics, a clinical stage biopharmaceutical company that is developing first-in-class therapeutics based on its proprietary Stapled Peptide drug platform, has announced that it has secured $33m in an extension to its Series E equity financing, bringing the total raised in this round to $48m.
Drug Research > Drug Discovery & Development > News
Akebia reports positive top-line results from Phase IIb AKB-6548 anemia trial
By PBR Staff Writer
Akebia Therapeutics has reported positive top-line results from its Phase IIb placebo-controlled trial of its once-daily, oral therapy, AKB-6548, in non-dialysis patients with anemia related to chronic kidney disease (CKD).
Drug Research > Drug Discovery & Development > News
Imprimis reports positive clinical findings of dropless cataract surgery
Imprimis Pharmaceuticals, a specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical compounded drug formulations, has reported clinical findings demonstrating the safety and benefits of Dropless cataract surgery and provided an update resulting from the recent American Academy of Ophthalmology (AAO) annual meeting held in Chicago, Illinois.
Drug Research > Drug Discovery & Development > News
View all Drug Discovery & Development news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250